title: In vivo manipulation (depletion versus activation) of testicular macrophages: central and local effects.
abstract: Testicular macrophages are a relevant cell type for the regulation of Leydig cell steroidogenesis. The availability of liposome technology allows in vivo manipulation of macrophages in order to analyze their role in the regulation of the hypothalamic-pituitary-testicular axis. In this study, adult (70 days of age) and prepubertal (22 days of age) rats were injected intratesticularly with liposomes containing either dichloromethylene diphosphonate (C12MDP) to deplete testicular macrophages or muramyl tripeptide (MTP-PE) to activate them. Control rats were injected with the corresponding volumes of 0.9% NaCl. Animals were killed 10 days after treatment. Adult rats injected bilaterally or unilaterally with C12MDP liposomes showed increased serum LH and testosterone concentrations, as well as increased testosterone concentrations in the testicular interstitial fluid. In unilaterally injected rats, testosterone concentrations in the interstitial fluid were higher in the macrophage-containing testes than in the contralateral, macrophage-depleted testes. Adult rats treated bilaterally with MTP-PE liposomes showed increased numbers of testicular macrophages, whereas the number of Leydig cells was unchanged. Serum LH concentrations were decreased, but no changes were found in testosterone concentrations. Prepubertal rats treated bilaterally with C12MDP liposomes showed decreased numbers of Leydig cells. However, serum LH and testosterone concentrations were increased. Otherwise, prepubertal rats treated bilaterally with MTP-PE liposomes showed increased numbers of macrophages and Leydig cells, as well as increased serum testosterone concentrations. These data suggest that testicular macrophage-derived factors act at two different levels in the pituitary-testicular axis: first, at a central level by inhibiting LH secretion, and secondly, at a local level by stimulating Leydig cell steroidogenesis.
authors.affiliation: Department of Cell Biology, University of Córdoba, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Gaytan
authors.forename: C
authors.initials: C
authors.lastname: Bellido
authors.forename: C
authors.initials: C
authors.lastname: Morales
authors.forename: M
authors.initials: M
authors.lastname: García
authors.forename: N
authors.initials: N
authors.lastname: van Rooijen
authors.forename: E
authors.initials: E
authors.lastname: Aguilar
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002452:Cell Count; D004002:Clodronic Acid / Q000494:pharmacology; D004337:Drug Carriers; D007985:Leydig Cells / Q000187:drug effects; D008081:Liposomes; D007986:Luteinizing Hormone / Q000097:blood*; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012741:Sexual Maturation / Q000502:physiology; D013737:Testis / Q000166:cytology*; D013739:Testosterone / Q000097:blood*
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D004002:Clodronic Acid; D013739:Testosterone; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C035104:muramylNAc-Ala-isoGln-Lys-tripeptide; D007986:Luteinizing Hormone